相关期刊:《Chinese Journal of Chemistry》《Acta Pharmacologica Sinica》《Journal of Biomaterials and Nanobiotechnology》《Advances in Bioscience and Biotechnology》更多>>
An efficient drug delivery is the prerequisite of the successful chemotherapeutic treatments of many human diseases. Despite a great number of approaches, the improvement of drug cell internalization remains an actual...
Project supported by the National Basic Research Program of China (973 Program) (No. 2010CB833200), the National Natural Science Foundation of China (Nos. 21032002, 20921091, 20672129, 20621062, 20772143) and the Chinese Academy of Sciences ("Knowledge Innovation", Nn. KJCX2.YW.H08)
A bioactive derivative of a natural diarylheptanoid containing a 1,3-anti diol motif was synthesized with the oxygen-carrying stereogenic centers taken from an enantiopure epoxy chiral building block derived from inex...
The effect of culture conditions on the production of bioactive secondary metabolites by the endophytic fungus Arthrinium State of Apiospora Montagnei Sacc. was investigated. Culture broths were partitioned with ethyl...
This work was supported by the Conselho Nacional de Desenvolvimento Científico e Tecnológico(CNPq);The authors also wish to thank Ronaldo Celerino da Silva and Sílvia Rafaelli Ramos for their valuable technical assistance.
Crataeva tapia bark lectin was evaluated for its antitumor activity against sarcoma 180 in Swiss albino mice.The anti-inflammatory and analgesic properties were investigated in models of inflammation and nociception.T...
Antimony, a natural element that has been used as a drug for over more than 100 years, has remarkable therapeutic efficacy in patients with acute promyelocytic leukemia. This review focuses on recent advances in devel...
supported by the Key Project of the Chinese Academy of Sciences(No.KSCX2-3-06);the National Natural Science Foundation of China(No.30120160823);the Chinese National“863”High Tech Project Foundation grant(No.2002AA216021).
ONYX-015 is an attractive therapeutic adenovirus for cancer because it can selectively replicate in tumor cells and kill them. To date, clinical trials of this adenovirus have demonstrated marked safety but not potent...